Also, resveratrol treatment (25 μM, 50 μM, 100 μM) limited the proliferation, migration, and invasion of neoplastic cells in renal cancer by inhibiting MMP-2 and MMP-9 and stimulating TIMP-1 by modulating the MAPK/ERK and PI3 K/Akt pathways [127]. Here, MMP9 is linked to renal carcinoma.